HTR1A and drug-induced dyskinesia: In all groups, dyskinesia could be substantially reduced or blocked by co-administration of the 5HT1A and 1B agonists (8-OH-DPAT and CP-94253, respectively) at doses affecting primarily the pre-synaptic auto-receptors (Gray bars in Fig 3B) [10]_ENREF_18.